<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dafni H</submitter><funding>NIBIB NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>7400-10</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2948586</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>70(19)</volume><pubmed_abstract>The recent development of hyperpolarized (13)C magnetic resonance spectroscopic imaging provides a novel method for in vivo metabolic imaging with potential applications for detection of cancer and response to treatment. Chemotherapy-induced apoptosis was shown to decrease the flux of hyperpolarized (13)C label from pyruvate to lactate due to depletion of NADH, the coenzyme of lactate dehydrogenase. In contrast, we show here that in PC-3MM2 tumors, inhibition of platelet-derived growth factor receptor with imatinib reduces the conversion of hyperpolarized pyruvate to lactate by lowering the expression of lactate dehydrogenase itself. This was accompanied by reduced expression of vascular endothelial growth factor and glutaminase, and is likely mediated by reduced expression of their transc</pubmed_abstract><journal>Cancer research</journal><pubmed_title>Hyperpolarized 13C spectroscopic imaging informs on hypoxia-inducible factor-1 and myc activity downstream of platelet-derived growth factor receptor.</pubmed_title><pmcid>PMC2948586</pmcid><funding_grant_id>R01 EB007588</funding_grant_id><funding_grant_id>R01-EB007588</funding_grant_id><funding_grant_id>R01-EB004453</funding_grant_id><funding_grant_id>R01 CA130819</funding_grant_id><funding_grant_id>R01 EB004453</funding_grant_id><funding_grant_id>R01-CA130819</funding_grant_id><pubmed_authors>Yoshihara HA</pubmed_authors><pubmed_authors>Vigneron DB</pubmed_authors><pubmed_authors>Dafni H</pubmed_authors><pubmed_authors>Hu S</pubmed_authors><pubmed_authors>Venkatesh HS</pubmed_authors><pubmed_authors>Larson PE</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Ronen SM</pubmed_authors><pubmed_authors>Ward CS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Hyperpolarized 13C spectroscopic imaging informs on hypoxia-inducible factor-1 and myc activity downstream of platelet-derived growth factor receptor.</name><description>The recent development of hyperpolarized (13)C magnetic resonance spectroscopic imaging provides a novel method for in vivo metabolic imaging with potential applications for detection of cancer and response to treatment. Chemotherapy-induced apoptosis was shown to decrease the flux of hyperpolarized (13)C label from pyruvate to lactate due to depletion of NADH, the coenzyme of lactate dehydrogenase. In contrast, we show here that in PC-3MM2 tumors, inhibition of platelet-derived growth factor receptor with imatinib reduces the conversion of hyperpolarized pyruvate to lactate by lowering the expression of lactate dehydrogenase itself. This was accompanied by reduced expression of vascular endothelial growth factor and glutaminase, and is likely mediated by reduced expression of their transc</description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 Oct</publication><modification>2025-04-19T09:49:13.631Z</modification><creation>2019-03-27T00:34:34Z</creation></dates><accession>S-EPMC2948586</accession><cross_references><pubmed>20858719</pubmed><doi>10.1158/0008-5472.CAN-10-0883</doi><doi>10.1158/0008-5472.can-10-0883</doi></cross_references></HashMap>